Showing results (111-120 of 160) with videos related to
Sort By:
Pageof 16
Biochemistry|April 8, 2021
Caught in Action: X-ray Structure of Thymidylate Synthase with Noncovalent Intermediate AnalogSvetlana A Kholodar, Janet S Finer-Moore, Katarzyna Świderek, et al.Diabetic Medicine : a Journal of the British Diabetic Association|May 17, 2011
Sequencing PDX1 (insulin promoter factor 1) in 1788 UK individuals found 5% had a low frequency coding variant, but these variants are not associated with Type 2 diabetesE L Edghill, A Khamis, M N Weedon, et al.Diabetologia|April 8, 2006
Common variations in the ALMS1 gene do not contribute to susceptibility to type 2 diabetes in a large white UK populationS Patel, J A L Minton, M N Weedon, et al.Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2002
Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetesH M Colhoun, M J Thomason, M I Mackness, et al.Diabetic Medicine : a Journal of the British Diabetic Association|July 24, 2004
Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetesM J Thomason, H M Colhoun, S J Livingstone, et al.Science (New York, N.Y.)|January 23, 1987
Atomic structure of thymidylate synthase: target for rational drug designL W Hardy, J S Finer-Moore, W R Montfort, et al.Proceedings of the National Academy of Sciences of the United States of America|July 5, 2014
Structure of a new DNA-binding domain which regulates pathogenesis in a wide variety of fungiMatthew B Lohse, Oren S Rosenberg, Jeffery S Cox, et al.Journal of Molecular Biology|November 25, 1998
Inactivity of N229A thymidylate synthase due to water-mediated effects: isolating a late stage in methyl transferC L Reyes, C R Sage, E E Rutenber, et al.Journal of Molecular Biology|March 26, 1998
Contributions of orientation and hydrogen bonding to catalysis in Asn229 mutants of thymidylate synthaseJ S Finer-Moore, L Liu, D L Birdsall, et al.Diabetologia|February 1, 2007
Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)M Raikou, A McGuire, H M Colhoun, et al.Pageof 16